Precigen, Inc. (PGEN)
3.71
-0.18
(-4.63%)
USD |
NASDAQ |
Mar 27, 13:22
Precigen Shareholders Equity (Quarterly) : 20.91M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 16.80M |
| Amneal Pharmaceuticals, Inc. | -70.79M |
| Corcept Therapeutics, Inc. | 647.80M |
| CorMedix, Inc. | 405.31M |
| Viridian Therapeutics, Inc. | 722.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 156.62M |
| Total Liabilities (Quarterly) | 135.71M |
| Debt to Equity Ratio | 4.700 |
| Current Ratio | 3.089 |
| Net Debt Paydown Yield | -1.25% |